The role of routine polio immunization in the post-certification era.
The role of routine vaccination against poliomyelitis for the post-certification era remains an important area for policy decision-making. Two critical decisions need to be taken: first, to continue or discontinue vaccination with the live attenuated oral poliovirus vaccine (OPV); and second, if OPV is to be discontinued, whether vaccination with inactivated poliovirus vaccine (IPV) is needed. Four potential vaccination scenarios can be constructed: stop all polio vaccination; continue with current vaccination policies (OPV, IPV, or sequential schedule); discontinue OPV, but continue IPV universally; or discontinue OPV, but continue IPV in selected countries. All possible scenarios require continued investments in a surveillance and response strategy, including a stockpile of polio vaccine. Continuing vaccination would limit the savings that could be applied to the control of other health priorities. This report reviews the key issues associated with each scenario, highlights the advantages and disadvantages of each scenario, and outlines the major challenges for policy decision-making.
Sutter
Roland W
RW
Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland. sutterr@who.int
Cáceres
Victor M
VM
Mas Lago
Pedro
P
D000367:Age Factors; D002568:Certification; D002648:Child; D002675:Child, Preschool; D005544:Forecasting; D006291:Health Policy; D006801:Humans; D017589:Immunization Programs; D007223:Infant; D011051:Poliomyelitis / Q000517:prevention & control*; D017955:Poliovirus / Q000472:pathogenicity; D011054:Poliovirus Vaccine, Inactivated / Q000008:administration & dosage; D011055:Poliovirus Vaccine, Oral / Q000008:administration & dosage; D023321:Poliovirus Vaccines / Q000008:administration & dosage*; D012307:Risk Factors
D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral; D023321:Poliovirus Vaccines